These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34224636)

  • 1. Hematopoietic stem cell-derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta.
    Kang IH; Baliga UK; Wu Y; Mehrotra S; Yao H; LaRue AC; Mehrotra M
    Stem Cells; 2021 Nov; 39(11):1457-1477. PubMed ID: 34224636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.
    Li H; Jiang X; Delaney J; Franceschetti T; Bilic-Curcic I; Kalinovsky J; Lorenzo JA; Grcevic D; Rowe DW; Kalajzic I
    Am J Pathol; 2010 May; 176(5):2405-13. PubMed ID: 20348238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model.
    Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I
    Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype.
    Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I
    Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies.
    Mehrotra M; Rosol M; Ogawa M; Larue AC
    Exp Hematol; 2010 Jul; 38(7):593-602. PubMed ID: 20417683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine.
    Matthews BG; Roeder E; Wang X; Aguila HL; Lee SK; Grcevic D; Kalajzic I
    Bone; 2017 Oct; 103():1-11. PubMed ID: 28600151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in the OIM model of osteogenesis imperfecta.
    Li N; Shi B; Li Z; Han J; Sun J; Huang H; Yallowitz AR; Bok S; Xiao S; Wu Z; Chen Y; Xu Y; Qin T; Huang R; Zheng H; Shen R; Meng L; Greenblatt MB; Xu R
    Bone Res; 2024 Aug; 12(1):46. PubMed ID: 39183236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
    Wang X; Li F; Niyibizi C
    Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
    Jones GN; Moschidou D; Abdulrazzak H; Kalirai BS; Vanleene M; Osatis S; Shefelbine SJ; Horwood NJ; Marenzana M; De Coppi P; Bassett JH; Williams GR; Fisk NM; Guillot PV
    Stem Cells Dev; 2014 Feb; 23(3):262-76. PubMed ID: 24028330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
    Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
    Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
    Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
    Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
    Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ
    Blood; 2011 Jan; 117(3):1053-60. PubMed ID: 21088133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta.
    Sun B; Wu H; Lu J; Zhang R; Shen X; Gu Y; Shi C; Zhang Y; Yuan W
    J Orthop Translat; 2023 Jan; 38():175-189. PubMed ID: 36439629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Marrow Transplantation for Treatment of the Col1a2
    Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A
    Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cells give rise to osteo-chondrogenic cells.
    Mehrotra M; Williams CR; Ogawa M; LaRue AC
    Blood Cells Mol Dis; 2013 Jan; 50(1):41-9. PubMed ID: 22954476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta.
    Li F; Wang X; Niyibizi C
    Bone; 2010 Sep; 47(3):546-55. PubMed ID: 20570757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
    Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
    Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
    Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
    Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.
    Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV
    Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim).
    Zimmerman SM; Heard-Lipsmeyer ME; Dimori M; Thostenson JD; Mannen EM; O'Brien CA; Morello R
    Bone Rep; 2018 Dec; 9():61-73. PubMed ID: 30105276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.